James Fisher & Sons plc (FSJ) — Research Note

Executive summary

James Fisher is a UK-listed marine services group operating across Energy (oil & gas well services, offshore wind, decommissioning), Defence (submarine rescue, diving equipment, special operations vehicles) and Maritime Transport (UK coastal tankers, ship-to-ship transfer). After a brutal 2020-2023 (multiple goodwill impairments totalling ~£75m, dive-support-vessel write-downs, refinancing, JFN nuclear disposal at £3, RMSpumptools sold for £82.8m, JFD project disappointments) the new CEO Jean Vernet has executed a credible turnaround: FY25 trading update (29-Jan-2026) flags revenue of ~£395m (+4% LFL), underlying operating profit ~£28m (ahead of £25.5m consensus) at ~7% margin, with net debt/EBITDA back inside the 1.0-1.5x target range. The single most important valuation point: the stock is priced at roughly fair value on FY25 numbers but with optionality on the path to a 10% margin / 15% ROCE medium-term target — meaning the upside requires successful execution of a turnaround that has only just begun delivering.

Fair value estimate

• Range: 380p – 540p per share; implied market cap £192m – £272m.
• Methodology: Blended EV/EBIT and forward P/E on FY26E/FY27E numbers.
• Key assumptions: FY26E revenue £405-415m (~3% organic growth, defence order book strengthening — order book £315m at June-25, +45% yoy 2025-09 H1); UOP £30-35m moving to £40m on a 2-3 year horizon if 10% target hit; covenant EBITDA ~£48m for FY26E; net debt covenant basis ~£70m. Applying 8-10x EV/EBIT to FY26E UOP ~£32m gives EV £256-320m, less ~£72m covenant net debt → equity £184-248m → 365-490p. On the bull-case 10% margin run-rate (UOP £40m), applying 9-11x → equity ~£290-370m → 575-735p, but heavily discounted for execution risk.
• Comparison to current £230.8m market cap (~458p): in line with the centre of our range — upside of c. +18% to mid-case 490p, downside of c. -17% to 380p. Stock is fair, neither obviously cheap nor obviously expensive.

Sector context

• ICB classification confirmed: Industrial Goods and Services, with significant Energy and Defence end-market exposure.
• Quality profile is below typical UK industrials peers: 7% UOP margin, 5% ROCE on LFL basis — well short of the 10%/15% medium-term targets. Balance sheet is improved but still carries material lease liabilities (~£80m).
• Listed peers (rough): James Fisher's closest UK comps include James Halstead is irrelevant; better comps are James Fisher itself has no perfect comp but partial-fit peers include Hunting plc (oil & gas services), Babcock International (defence/marine services), and John Wood Group (energy services). On EV/EBITDA, FSJ trades broadly in line with Hunting and at a discount to Babcock.

Investment thesis (3 bullets)

1. Turnaround momentum is real and visible in the numbers. FY25 UOP ahead of consensus at ~£28m vs £25.5m, margin moving from 5.7% (H1-24) to 5.8% LFL (H1-25) to ~7% (FY25E), with net debt:EBITDA back inside the 1.0-1.5x target. Defence order book up 45% yoy to £315m 2025-09 H1 results; src: 2026-01 FY25 trading update.
2. Genuine niche assets in submarine rescue, bubble curtains (offshore wind piling noise mitigation) and Tankships fleet renewal. Defence wins include NATO submarine rescue renewal, Polish Navy contract, US Special Security Agreement, Saab partnership. Tankships running 89-90% utilisation with four new dual-fuel vessels delivering 2026-27 2025-03 FY24 results; src: 2025-09 H1 results.
3. Self-help still ahead. Path from 7% to 10% UOP margin via supply-chain integration, Defence revenue recovery, business-unit performance improvements — none of which require heroic market assumptions. £1m supply chain savings delivered FY24, more flagged 2025-03 FY24 results.

Key risks (3 bullets)

1. Execution risk on the turnaround. History of repeated guidance misses 2020-2023 and material adjusting items (goodwill impairments £28m in 2023, multiple business writedowns) — the new management has only ~18 months' track record and the path to 10% margin still requires significant operational delivery 2025-03 FY24 results.
2. Cyclical end-market exposure. FY25 trading update flags "softness in oil and gas in the second half" and "well testing" weakness; Fendercare ship-to-ship transfer revenue down 25% in H1-25 on lower LNG STS activity. Energy revenue down 22% reported in H1-25 2025-09 H1; src: 2026-01 trading update.
3. Balance sheet still carries meaningful constraints. Net debt £142.7m on reported basis (incl. £81m IFRS16 leases), four new tanker leases adding £46m of right-of-use additions in H1-25; covenant headroom on liquidity remained "limited" under severe-but-plausible scenarios per the going-concern review; effective interest rate on borrowings c.8.5% 2025-09 H1 results; src: 2025-03 FY24 results.

Operating leverage

James Fisher has moderate operating leverage. The business mix is genuinely fixed-cost-heavy in parts: the Tankships fleet (15+ vessels, 89-90% utilisation), Defence facilities and long-cycle project businesses (JFD submarine rescue, JFN diving systems), and Energy services where compressor fleets and bubble-curtain equipment carry meaningful fixed depreciation (£44m group D&A on £438m revenue in FY24). The Defence segment is the clearest operating-leverage story: H1-25 revenue grew just 3.0% but underlying operating profit swung from a £0.4m loss to a £0.7m profit (margin +300bps), and the £315m order book gives multi-year visibility 2025-09 H1 results. However, much of the cost base — vessel charters, project labour, shipping fuel, ship-to-ship vessel costs — does scale with revenue, so the group as a whole is closer to typical industrial leverage than to pure software/platform leverage. A 10-20% revenue beat would plausibly add 30-50% to operating profit (taking UOP from £28m to £38-42m), not multiples. The 10% medium-term margin target implies £40m UOP on £400m revenue — credible but not a doubling.

Value-trap signals

• Multi-year history of guidance misses and goodwill writedowns (2020-2023) — though the new management team has begun to reverse this.
• No dividend since 2020; Board committed to reinstating "at the appropriate time" but no firm date.
• Operations in emerging markets (Mozambique LNG project delays, Saudi Arabia, Brazil, Africa) with associated regulatory and counterparty risk; offset penalty provisions of £3m disclosed.
• Effective tax rate distorted by withholding taxes in higher-tax jurisdictions (75.6% ETR in H1-25 on underlying basis).
• Heavy reliance on alternative performance measures; reported numbers materially below underlying due to adjusting items.

Earnings vs. expectations

The trajectory has shifted decisively. 2020-2023 was a series of misses: 2021 trading update Oct-2021 flagged contract disputes, customer bad debts and delayed projects vs prior guidance; 2022 H1 trading update flagged Specialist Technical revenue at "a cyclical low point"; FY22 results delayed twice and required parent-company-guarantee waivers from lenders. 2024 was the inflection: FY24 trading update (5-Feb-2025) flagged UOP of c.£29m "ahead of current market expectations" helped by non-recurring items, and FY24 results delivered. 2025 has continued the beat: H1-25 results (9-Sept-2025) showed UOP up 14.4% LFL "in line with expectations"; FY25 trading update (29-Jan-2026) flagged UOP ahead of £25.5m consensus at c.£28m. Pattern: years of misses followed by ~18 months of meeting or modestly beating — encouraging but not yet a consistent track record.

Conviction

Conviction: 3 (moderate). Anchored by (i) clean H1-25 disclosure with detailed segmental data, (ii) management consensus expectation explicitly disclosed (£25.5m UOP) allowing independent calibration, and (iii) consistent guidance from the new management team since early-2024. Limited by (a) historical volatility in earnings (multiple restatements, going-concern emphasis in 2022 and 2024 auditor reports) which makes the underlying earnings power harder to anchor with confidence, and (b) heavy use of alternative performance measures with material adjusting items that vary year to year. A different methodology — DCF or sum-of-parts — could plausibly produce a 30-40% wider range.

Driver scoring rationale

• AI beneficiary: 8 — a marine services and industrial company. Zero direct AI exposure. Some technology innovation (digital twin/AIS, ROVs, autonomous capability in defence systems) but the value chain has no meaningful link to AI buildout, AI data centres, AI tooling, or any agentic-AI value capture.
• Operating leverage: 45 — moderate. Some fixed-cost businesses (Tankships, Defence facilities, compressor fleets) and capacity-constrained services with pricing power, but ship-to-ship, marine contracting and most Energy work scale variably with revenue.
• Earnings surprise trend: 55 — currently beating on the back of new management's reset, but only ~18 months of track record after a prior pattern of misses.
• Cyclicality: 65 — oil & gas exposure, defence procurement cycles, maritime trading conditions; H1-25 already flagged "softness in oil and gas".
• Moat: 45 — genuine niches in submarine rescue, bubble curtains, certain UK coastal Tankships routes, but commodity exposure in dive support, ship-to-ship, decommissioning.
• Leverage: 45 — net debt/EBITDA 1.6x on covenant basis at H1-25, within target range but materially elevated on a reported basis (~3.3x including IFRS16 leases).
• Earnings quality: 40 — heavy adjusting items, multiple goodwill impairments, IFRS16 and APM noise, restatements during 2022/2023 audit process.
• Management quality: 55 — new CEO (Vernet, Sept-2022), new CFO (Hayzen-Smith, Dec-2023), new Chair (Cockburn, 2021) executing visible turnaround; predecessor team oversaw value destruction.
• Growth momentum: 55 — 4% LFL revenue growth FY25, margin expansion from 5.7% to 7%, Defence order book +45%.

Overall score rationale

This is a credible UK industrial turnaround at fair value, but it scores poorly against this investor's specific filters: near-zero AI beneficiary exposure, only moderate operating leverage, and a valuation that is fair rather than cheap. Acceptable downside protection (improving balance sheet, real assets, dividend reinstatement on the horizon) but the strategic fit is the binding constraint — there is no plausible "long-tail AI upside" pathway.